{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Active+Comparator+2&page=10", "query": { "intervention": "Active Comparator 2", "page": 10 }, "page_size": 10 }, "pagination": { "page": 10, "page_size": 10, "total_count": 941, "total_pages": 95, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Active+Comparator+2&page=11&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Active+Comparator+2&page=9&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T23:58:30.549Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07740291", "title": "Tirzepatide Impact Assessment Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity & Overweight", "Cardiometabolic Health Indicators", "Addiction", "Eating Disorders", "Mental Health" ], "interventions": [ { "name": "GLP-1 Receptor Agonist Therapy", "type": "DRUG" }, { "name": "Structured Lifestyle Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Texas Tech University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2025-01-02", "completion_date": "2026-12-07", "has_results": false, "last_update_posted_date": "2026-07-31", "last_synced_at": "2026-10-21T23:58:30.549Z", "location_count": 1, "location_summary": "Lubbock, Texas", "locations": [ { "city": "Lubbock", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07740291" }, { "nct_id": "NCT00424190", "title": "Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bacterial Infections" ], "interventions": [ { "name": "IV Vancomycin plus IV Aztreonam", "type": "DRUG" }, { "name": "Ceftaroline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 698, "start_date": "2007-02", "completion_date": "2007-11", "has_results": true, "last_update_posted_date": "2017-03-14", "last_synced_at": "2026-10-21T23:58:30.549Z", "location_count": 15, "location_summary": "Dothan, Alabama • Long Beach, California • Los Angeles, California + 11 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00424190" }, { "nct_id": "NCT05698368", "title": "Digital Knee Osteoarthritis Mindset Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Knee Osteoarthritis" ], "interventions": [ { "name": "Mindset intervention", "type": "BEHAVIORAL" }, { "name": "Active comparator", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 458, "start_date": "2023-04-10", "completion_date": "2023-09-19", "has_results": true, "last_update_posted_date": "2025-02-13", "last_synced_at": "2026-10-21T23:58:30.549Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05698368" }, { "nct_id": "NCT03507374", "title": "PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Stroke", "Intracranial Atherosclerosis", "Intraplaque Hemorrhage" ], "interventions": [ { "name": "Alirocumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2018-10-30", "completion_date": "2020-04-17", "has_results": false, "last_update_posted_date": "2020-04-21", "last_synced_at": "2026-10-21T23:58:30.549Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03507374" }, { "nct_id": "NCT03893448", "title": "Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Infections", "Pneumococcal Vaccines" ], "interventions": [ { "name": "V114", "type": "BIOLOGICAL" }, { "name": "Prevnar 13™", "type": "BIOLOGICAL" }, { "name": "RotaTeq™", "type": "BIOLOGICAL" }, { "name": "Pentacel™", "type": "BIOLOGICAL" }, { "name": "RECOMBIVAX HB™", "type": "BIOLOGICAL" }, { "name": "VAQTA™", "type": "BIOLOGICAL" }, { "name": "MMR II™", "type": "BIOLOGICAL" }, { "name": "VARIVAX™", "type": "BIOLOGICAL" }, { "name": "HIBERIX™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "90 Days", "sex": "ALL", "summary": "42 Days to 90 Days" }, "enrollment_count": 1720, "start_date": "2019-06-19", "completion_date": "2021-05-24", "has_results": true, "last_update_posted_date": "2023-07-28", "last_synced_at": "2026-10-21T23:58:30.549Z", "location_count": 66, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Opp, Alabama + 58 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Opp", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03893448" }, { "nct_id": "NCT07755735", "title": "A Study to Evaluate the Effects of a Fiber Supplement on Gut Health", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gut Health", "Bloating", "Irregular Bowel Movements", "Gastrointestinal Symptoms" ], "interventions": [ { "name": "Active Supplement", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo Comparator", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Belli Welli Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2025-08-26", "completion_date": "2026-01-12", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-21T23:58:30.549Z", "location_count": 1, "location_summary": "Las Vegas, Nevada", "locations": [ { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT07755735" }, { "nct_id": "NCT04498117", "title": "Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Carcinoma, Ovarian Epithelial", "Ovarian Neoplasms", "Ovarian Cancer", "Ovarian Serous Adenocarcinoma", "Fallopian Tube Neoplasms", "Fallopian Tube Adenocarcinoma", "Fallopian Tube Serous Adenocarcinoma", "Peritoneal Cancer", "Peritoneal Carcinoma", "Peritoneal Neoplasms" ], "interventions": [ { "name": "Oregovomab", "type": "BIOLOGICAL" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "CanariaBio Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 615, "start_date": "2020-08-25", "completion_date": "2028-08-26", "has_results": false, "last_update_posted_date": "2026-04-01", "last_synced_at": "2026-10-21T23:58:30.549Z", "location_count": 81, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Concord, California + 70 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Concord", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04498117" }, { "nct_id": "NCT04753034", "title": "Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "TER-101", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teres Bio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 63, "start_date": "2021-01-18", "completion_date": "2021-05-03", "has_results": true, "last_update_posted_date": "2022-07-26", "last_synced_at": "2026-10-21T23:58:30.549Z", "location_count": 12, "location_summary": "Scottsdale, Arizona • Encinitas, California • North Miami Beach, Florida + 9 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "North Miami Beach", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Clarksville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04753034" }, { "nct_id": "NCT03319498", "title": "Postpartum Urinary Retention With Essential Oils (PURE)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Urinary Retention" ], "interventions": [ { "name": "Peppermint Oil Vapor", "type": "OTHER" }, { "name": "Mineral Oil Vapor", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Mount Carmel Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 77, "start_date": "2018-01-01", "completion_date": "2026-02-16", "has_results": false, "last_update_posted_date": "2026-03-05", "last_synced_at": "2026-10-21T23:58:30.549Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03319498" }, { "nct_id": "NCT07732699", "title": "Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Sinusitis)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "ACUTE SINUSITIS", "Sinusitis" ], "interventions": [ { "name": "Amoxicillin", "type": "DRUG" }, { "name": "Amoxi Clavulanate", "type": "DRUG" }, { "name": "Amoxicillin Placebo", "type": "DRUG" }, { "name": "Amoxicillin-Clavulanate Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nader Shaikh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "2 Years to 12 Years" }, "enrollment_count": 1100, "start_date": "2026-10-01", "completion_date": "2032-03-17", "has_results": false, "last_update_posted_date": "2026-10-20", "last_synced_at": "2026-10-21T23:58:30.549Z", "location_count": 5, "location_summary": "Denver, Colorado • Durham, North Carolina • Cincinnati, Ohio + 2 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT07732699" } ] }